- Product Details
Keywords
- 137071-32-0 China manufacture
- Supply Pimecrolimus
- Buy 137071-32-0
Quick Details
- ProName: Buy Supply Pimecrolimus 137071-32-0 Ch...
- CasNo: 137071-32-0
- Molecular Formula: C43H68ClNO11
- Appearance: refer to COA
- Application: Immunosuppressant
- DeliveryTime: Normally in stock
- PackAge: 25kg/drum or client's request
- Port: SHANGHAI PORT
- ProductionCapacity: 15 Metric Ton/Month
- Purity: refer to COA
- Storage: Store in a well-closed place with room...
- Transportation: By sea; By air;by courier
- LimitNum: 1 Kilogram
Superiority
Properties of pimecrolimus
Melting point: 135-136°C
Boiling point 866.1±75.0°C(Predicted
) Density 1.19
Storage conditions KeepiChemicalbookndarkplace, Sealedindry, 2-8°C
Acidity coefficient (pKa) 9.97±0.70 (Predicted)
Details
CAS :137071-32-0
Density:1.19g/cm3
Boiling point:866.1°C at 760 mmHg
Refractive index:1.543
Flash point:477.6°C
Vapour Pressur:5.44E-35mmHg at 25°C
Chemical Name | Pimecrolimus |
---|---|
Synonyms |
|
CAS No. | 137071-32-0 |
Molecular Formula | C43H68ClNO11 |
Molecular Weight | 810.45300 |
PSA | 158.13000 |
LogP | 5.65730 |
Properties
Appearance & Physical State | white crystalline powder |
---|---|
Density | 1.19 |
Boiling Point | 866.1ºC at 760 mmHg |
Flash Point | 477.6ºC |
Refractive Index | 1.543 |
Vapor Pressure | 5.44E-35mmHg at 25°C |
Function
In vitro studies
Pimecrolimus blocks the activation pathway of T lymphocytes by inhibiting the function of phosphatase.
Pimecrolimus prevents the release of cytokines and pro-inflammatory mediators from mast cells.
Pimecrolimus binds to macrophilin-12 to form a pimecrolimus-macrophilin complex, which then binds to the cytoplasmic enzyme calcineurin.
Pimecrolimus-macrophilin complex Chemicalbook compound inhibits the action of calcineurin to prevent the dephosphorylation of the cytoplasmic components of nuclear factors in activated T cells.
Pimecrolimus not only inhibits the transcription and synthesis of cytokines in mast cells, but also inhibits the release of pre-formed mediators serotonin and β-hexosaminidase by inhibiting Fcε-RI-mediated degranulation and secretion.
Pimecrolimus treatment caused a strong down-regulation of the mRNA expression of genes related to the macrolactam target pathway and inflammation.